For FALS, genetic interventions focused on knocking down key genes such as mutant form of super oxide dismutase 1 (SOD1) 5, however, due to the lesser-known etiology of SALS, a successful therapy for ALS will most likely require combinatorial neuroprotective interventions. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.